Studying human diseases like cancer presents significant challenges, particularly when it comes to accurately replicating tumor behavior in the laboratory. Traditionally, researchers have relied on animal models and human cell lines to simulate cancer-like conditions. However, these systems often fail to fully capture the complexity of human tumors. In recent years, patient-derived organoids and spheroids have emerged as powerful tools, offering a more physiologically relevant model for studying cancer biology and testing new therapies.